Skip to content

Clinical trials

Attention Deficit Disorder with Hyperactivity trials in the United States with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Attention Deficit Disorder with Hyperactivity Phase: Not applicable Country / region: United States Clear all

280 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20014
20021
20032
20041
20055
20066
20076
20085
20097
20108
20115
201214
20138
201417
201519
201617
201713
201817
201911
20208
202117
202222
202315
202417
202521
202613

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed186
Recruiting41
Unknown status14
Active, not recruiting13
Terminated10
Withdrawn9
Not yet recruiting4
Enrolling by invitation2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Hospital Medical Center, Cincinnati24
Massachusetts General Hospital18
Florida International University11
Duke University9
University of California, San Francisco9
Akili Interactive Labs, Inc.7
Children's Hospital of Philadelphia7
NYU Langone Health7
University of California, Los Angeles7
University of Pittsburgh7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Attention Deficit Disorder with Hyperactivity280
Oppositional Defiant Disorder11
Autism Spectrum Disorder10
Autistic Disorder9
Anxiety Disorders8
Attention Deficit and Disruptive Behavior Disorders8
Substance-Related Disorders7
Conduct Disorder6
Parasomnias5
Spasm5

Trials

Showing 1 to 25 of 280. Each trial links to its page on Pharma Observatory.

180 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.